At least 11 biotechs and pharmas are reporting earnings this week. Amgen Inc. (NASDAQ:AMGN), Celgene Corp. (NASDAQ:CELG) and Cubist Pharmaceuticals Inc. (NASDAQ:CBST) are all expected to report at least a 19% jump in EPS. Top-line growth for Amgen is expected to be up 10% to $4.4 billion in 4Q12, while